Edition:
United States

People: Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

43.60USD
26 Jul 2016
Change (% chg)

$0.19 (+0.44%)
Prev Close
$43.41
Open
$43.39
Day's High
$43.62
Day's Low
$43.37
Volume
1,674,652
Avg. Vol
2,421,535
52-wk High
$51.23
52-wk Low
$36.00

Warmuth, Michael 

Mr. Michael J. Warmuth is Executive Vice President - Established Pharmaceuticals of Abbott Laboratories, since November 2012. Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott's Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations. He earned a bachelor's degree in business administration from the University of Wisconsin-Whitewater and a master's degree in business administration from Northwestern University.

Basic Compensation

Total Annual Compensation, USD 1,375,000
Restricted Stock Awards, USD 1,207,090
Long-Term Incentive Plans, USD --
All Other, USD 2,189,190
Fiscal Year Total, USD 4,771,290

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Miles White

19,401,700

Brian Yoor

3,008,220

Thomas Freyman

6,067,650

Hubert Allen

3,772,840

Stephen Fussell

5,750,460

Richard Ashley

3,640,640
As Of  30 Dec 2015